Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This molecule is a human pseudogene sequence homologous to the AQN-1 protein from Sus scrofa (pig)[1]. Pseudogenes are DNA sequences resembling genes but typically lack the ability to encode functional proteins[4][6]. They can arise via gene duplication (unprocessed), retrotransposition (processed), or gene disabling (unitary), and may retain high sequence homology to their ancestral functional genes[2][3][4][6]. Although most pseudogenes are considered nonfunctional, some may contribute to gene regulation, for instance by generating regulatory RNAs or acting as endogenous microRNA sponges[5][3]. For ENSG00000286114, its biological role and clinical relevance are unproven and require further investigation. It is not currently classified as a receptor, enzyme, or any canonical drug target[1][4][6]. Key points: - Not a validated therapeutic target - No evidence for functional protein or direct involvement in drug action - Current status is a putative pseudogene with incomplete descriptive and functional data[1][4][6]
None; pseudogenes generally lack mechanisms of drug action due to non-functionality
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel pseudogene similar to AQN-1 protein AQN-1 (Sus scrofa) (ENSG00000286114).